Affiliated Focus Groups

Computational Drug Design
Dermatopharmaceutics
Excipients
Inhalation and Nasal Technology
Intellectual Property
Lipid-Based Drug Delivery Systems
Modified Release
Nanotechnology
Oral Absorption
Preformulation
Prodrug

Physical Pharmacy and Biopharmaceutics

The Physical Pharmacy and Biopharmaceutics (PPB) Section is composed of members whose scientific interests are in the physicochemical and biological factors that impact the molecular design and delivery of small drug molecules. PPB provides a forum for the exchange of information pertaining to the selection of developable drug candidates at the drug discovery-drug development interface, intrinsic physicochemical properties of drugs, solid-state characterization of active pharmaceutical ingredients and excipients, preformulation testing leading to the selection of formulation strategies, and selection of delivery routes through the physiological considerations of drug delivery at the cellular, organ and whole animal levels. PPB is a multidisciplinary section which focuses on a quantitative understanding of the intrinsic properties of the molecule and the interacting biological system, enabling the selection of developable drug candidates and the identification of potential strategies for optimal drug delivery.

Please check back frequently for more information about the brand new PPB Section!

The archived websites for the Pharmaceutics and Drug Delivery (PDD) Section and the
Pharmaceutical Technologies (PT) Section are still available for access.

Chair
Lawrence X. Yu, Ph.D.

North Potomac, MD UNITED STATES

Chair-Elect
Michael J. Hageman, Ph.D.
Bristol-Myers Squibb
Princeton, NJ UNITED STATES

Vice Chair
Duxin Sun, Ph.D.
University of Michigan
Ann Arbor, MI UNITED STATES

Secretary/Treasurer
Tycho H. Heimbach, Ph.D.
Novartis Pharmaceuticals Corporation
East Hanover, NJ UNITED STATES

Annual Meeting Screeners Committee
Nathalie Y. Toussaint, Ph.D.
Bristol-Myers Squibb
Princeton, NJ United States

Annual Meeting Program Committee
Michael J. Hageman, Ph.D.
Bristol-Myers Squibb
Princeton, NJ UNITED STATES

Content Advisory Cmte
Naushad M. Khan Ghilzai, Ph.D.
LECOM School of Pharmacy
Erie, PA United States

Student/Postdoc Committee
AYMAN FAWZI EL-KATTAN, Ph.D
Pfizer Inc.
Groton, CT

Fellows Committee
Gregory E. Amidon, Ph.D.
University of Michigan
Ann Arbor, MI United States

Nominations Committee
Lawrence X. Yu, Ph.D.

North Potomac, MD UNITED STATES

Program Coordination Committee
Michael J. Hageman, Ph.D.
Bristol-Myers Squibb
Princeton, NJ UNITED STATES

Member Strategic Oversight Committee
Pei Fan Bai, Ph.D.
OCP/OTS/CDER/FDA
Silver Spring, MD

Webmasters Committee
Sherry M. Ku
Wyeth Research
Pearl River, NY

Communications Committee
Balvinder S. Vig, Ph.D
Bristol Myers Squibb
New Brunswick, NJ UNITED STATES

Executive Council Liaison
Patrick J. McNamara, Ph.D.
University of Kentucky
Lexington, KY UNITED STATES

Staff Liaison
Peter Inchauteguiz
AAPS
Arlington, VA UNITED STATES

Excipients Focus Group
Brian AC Carlin, Ph.D.
FMC BioPolymer
Princeton, NJ

Computational Drug Design Focus Group
Prof. Chang-Guo Zhan
University of Kentucky
Lexington, KY UNITED STATES

Inhalation & Nasal Technology Focus Group
Jill K. Sherwood
N/A
Southington, CT United States

Intellectual Property Focus Group
Eyal H. Barash, J.D.
SSCI Inc
West Lafayette, IN UNITED STATES

Lipid-Based Drug Delivery Systems Focus Group
Panayiotis P. Constantinides, Ph.D.
Biopharmaceutical and Drug Delivery Consulting, LLC
Gurnee, IL UNITED STATES

Microdialysis Focus Group
Dr. Grazia Stagni
Long Island University
Brooklyn, NY UNITED STATES

Modified Release Focus Group
John R. Crison, Ph.D.
Simulations Plus
Lancaster, CA UNITED STATES

Nanotechnology Focus Group
Patrick J. Sinko, Ph.D.
Rutgers University College of Pharmacy
Piscataway, NJ UNITED STATES

Ocular Drug Delivery & Disposition Focus Group
Dr. Brian R. Rohrs
Bausch & Lomb
Rochester, NY UNITED STATES

Oral Absorption Focus Group
Dr. Praveen V. Balimane
Bristol-Myers Squibb
Princeton, NJ United States

Preformulation Focus Group
Eric J. Munson, Ph.D
University of Kansas
Lawrence, KS

Preformulation Focus Group
Tapan K. Das, Ph.D.
Pfizer, St. Louis
Chesterfield, MO United States

Prodrug Focus Group
Duxin Sun, Ph.D.
University of Michigan
Ann Arbor, MI UNITED STATES